Background
Long-term survivors of childhood acute lymphoblastic leukemia (ALL) are at risk for neurocognitive impairment, which may be associated with fatigue, sleep problems, systemic inflammation and oxidative stress. We examined these associations among survivors of childhood ALL treated with chemotherapy only.
Methods
Survivors of ALL (N=70, 50% males, mean[SD] age 14.3[4.7] years; 7.4[1.9] years post-diagnosis) completed neurocognitive testing, behavioral ratings, and reported sleep quality and fatigue symptoms at ≥5 years post-diagnosis. Serum was collected concurrently and assayed for interleukin 1-Beta and 6 (IL-1β, IL-6), tumor necrosis factor alpha (TNF-α), high-sensitivity C-reactive protein (hsCRP), malondialdehyde, myeloperoxidase and oxidized low-density lipoprotein. General linear modeling was used to assess associations among biomarkers and functional outcomes, adjusting for age and stratified by sex.
Results
Survivors performed worse than population norms on executive function and processing speed, and reported more behavioral problems (P’s<0.05 adjusted for multiple comparison). In female survivors, fatigue was associated with poor executive function (r=0.41; P=0.02), processing speed (r=0.56; P<0.001) and attention (r=0.36 to 0.55; P’s<0.05). Female survivors with frequent nighttime awakening displayed more inattention (P=0.01), hyperactivity (P=0.03), and aggression (P=0.01). Worse executive function, processing speed and behavioral symptoms were observed in female survivors with higher IL-6, IL-1β and hsCRP (P’s<0.05). Male survivors with high TNF-α demonstrated worse organization (P=0.03), but no significant associations between neurocognitive outcomes and sleep/fatigue measures were observed.
Conclusion
Neurocognitive function in female survivors appears more susceptible to the effects of sleep disturbance and fatigue. Systemic inflammation may play a role in neurocognitive impairment and behavioral symptoms.